Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide continuation in glioblastoma
NCT02209948Phase 2Completed
- Sponsor
- Grupo Español de Investigación en Neurooncología
- Start
- Aug 2014
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in glioblastoma (GBM), sponsored by Grupo Español de Investigación en Neurooncología. Started Aug 2014; status: completed.
02
Drugs
temozolomide
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT02209948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02209948.